Androgen control of lipid metabolism in prostate cancer: novel insights and future applications
- 1School of Medicine, University of Adelaide, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
- 2Laboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI – Leuven Cancer Institute, KU Leuven – University of Leuven, Leuven, Belgium
- Correspondence should be addressed to J V Swinnen; Email: johan.swinnen{at}med.kuleuven.be
Abstract
One of the most typical hallmarks of prostate cancer cells is their exquisite dependence on androgens, which is the basis of the widely applied androgen deprivation therapy. Among the variety of key cellular processes and functions that are regulated by androgens, lipid metabolism stands out by its complex regulation and its many intricate links with cancer cell biology. Here, we review our current knowledge on the links between androgens and lipid metabolism in prostate cancer, and highlight recent developments and insights into the links between key oncogenic stimuli and altered lipid synthesis and/or uptake that may hold significant potential for biomarker development and provide new vulnerabilities for therapeutic intervention.
- Received 26 April 2016
- Accepted 28 April 2016
- Made available online as an Accepted Preprint 1 May 2016
- © 2016 Society for Endocrinology
